CONSIDERING QUESTION OF SAFETY OF DIRECT ORAL ANTICOAGULANTS: THE RESULTS OF THE COMPARISON OF APIXABAN AND WARFARIN

The review analyzes data on the safety of apixaban for the prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation and venous thromboembolic complications obtained in randomized controlled studies.

Bibliographic Details
Main Author: Igor S. Yavelov
Format: Article
Language:Russian
Published: «REMEDIUM GROUP» Ltd. 2018-12-01
Series:Атеротромбоз
Subjects:
Online Access:https://www.aterotromboz.ru/jour/article/view/166